, Tracking Stock Market Picks
Enter Symbol:
Kronos Worldwide Inc (KRO) [hlAlert]

down 69.76 %

Kronos Worldwide Inc (KRO) rated Buy with price target $32 by Standpoint Research

Posted on: Friday,  Mar 2, 2012  11:25 AM ET by Standpoint Research

Standpoint Research rated Buy Kronos Worldwide Inc (NYSE: KRO) on 03/02/2012, when the stock price was $24.08. Since
then, Kronos Worldwide Inc has lost 69.77% as of 12/14/2015's recent price of $7.28.
If you would have followed this Standpoint Research's recommendation on KRO, you would have lost 69.76% of your investment in 1382 days.

Kronos Worldwide, Inc. is a global producer and marketer of value-added titanium dioxide pigments (TiO2). The Company, along with its distributors and agents, sells and provides technical services for its products to over 4,000 customers in approximately 100 countries with sales in Europe and North America. The Company also owns and operates an ilmenite mine in Norway, manufactures and sells iron-based chemicals, which are co-products and processed co-products of sulfate and chloride process TiO2 pigment production, and manufacture and sell titanium oxychloride and titanyl sulfate, which are side-stream products from the production of TiO2. The Company?s subsidiary is Louisiana Pigment Company, L.P.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/2/2012 11:25 AM Buy
24.08 32.00
as of 12/31/2012
1 Week up  11.23 %
1 Month up  21.04 %
3 Months up  30.52 %
1 YTD down  -19.01 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy